News

The Food and Drug Administration announced its approval of the implant ENCELTO as the first treatment for macular telangiectasia.

Researchers at the University of Michigan recently published results of a study that focused on the dependence of photoreceptors on the amino acid, glutamine.

A recent study highlights the relationship between the severity of diabetic retinopathy and the risk of heart failure for patients who also have chronic kidney disease.  

Clinical trials are set to launch later this year to evaluate whether the cancer drug, PRL3-zumab, is effective in treating wet age-related macular degeneration (AMD) as well as diabetic retinopathy.

Researchers recently sought to determine the role vitamin D plays in the development of diabetic macular ischemia (DMI), which is an irreversible diabetic maculopathy.

A recent study conducted by researchers at the Washington University School of Medicine found that a molecule may hold the key in reversing age-related macular degeneration.

A study that was recently published in Food Science & Nutrition reveals that instant coffee drinkers had almost 8 times the increased risk of developing dry age-related macular degeneration.

This year has seen several eye drop recalls already and yet another one has been added to this list. While previous recalls have involved over-the-counter eye drops, the latest recall is for prescr...

Semaglutide, a popular diabetes and weight loss drug, has been found to double the risk of developing neovascular age-related macular degeneration (nAMD) in older patients with diabetes.